Freitas Eduardo D S, Roust Lori R, De Filippis Eleanna, Buras Matthew, Brown Brooke, Katsanos Christos S
School of Life Sciences, Arizona State University, Tempe, Arizona, USA.
College of Medicine, Mayo Clinic Arizona, Scottsdale, Arizona, USA.
Physiol Rep. 2025 Jun;13(12):e70436. doi: 10.14814/phy2.70436.
We investigated how obesity impacts the response of circulating insulin-like growth factor-1 (IGF-1) to a single bout of endurance exercise in humans with and without obesity. Blood samples were collected before exercise, at 15 and 40 min during a 45-min cycling session at 65% of heart rate reserve, and 15 min post-exercise. Serum levels of total IGF-1, free IGF-1, IGF binding proteins 1 (IGFBP-1) and 3 (IGFBP-3), growth hormone, and insulin were measured. Both total IGF-1 and IGFBP-3 serum concentrations increased significantly (p < 0.05) during exercise in the study participants without obesity but not in those with obesity, returning to basal levels immediately after exercise. There was a statistically significant main effect on the growth hormone response, with circulating levels being higher in participants without obesity (p < 0.05). No significant effects were observed for either free IGF-1 or IGFBP-1 serum concentrations in response to exercise in either group (p > 0.05). We conclude that humans with obesity have blunted serum total IGF-1 response during exercise. However, a concurrent attenuation in serum IGFBP-3 response, which regulates free (i.e., biologically active) IGF-1 in circulation, results in no change in circulating free IGF-1 levels during endurance exercise in individuals with obesity.
我们研究了肥胖如何影响有肥胖症和无肥胖症的人群单次耐力运动后循环胰岛素样生长因子-1(IGF-1)的反应。在运动前、45分钟骑行运动(强度为心率储备的65%)的15分钟和40分钟时以及运动后15分钟采集血样。检测血清中总IGF-1、游离IGF-1、IGF结合蛋白1(IGFBP-1)和3(IGFBP-3)、生长激素和胰岛素的水平。在无肥胖症的研究参与者中,运动期间总IGF-1和IGFBP-3血清浓度显著升高(p<0.05),但肥胖者中未出现这种情况,运动后立即恢复到基础水平。对生长激素反应有统计学显著的主效应,无肥胖症参与者的循环水平更高(p<0.05)。两组中,运动对游离IGF-1或IGFBP-1血清浓度均未产生显著影响(p>0.05)。我们得出结论,肥胖者运动期间血清总IGF-1反应减弱。然而,血清IGFBP-3反应同时减弱,而IGFBP-3可调节循环中游离(即生物活性)IGF-1,导致肥胖个体耐力运动期间循环游离IGF-1水平无变化。